News
Immpact Bio receives FDA Clearance for CAR T Therapy developed at UCLA
Dual CD19 and CD20-targeting CAR T therapy offers broad immune targeting and potential to reset immune system
No neurotoxicity and only Grade 1 cytokine release syndrome in ongoing UCLA investigator-led study in lymphoma
UCLA TDG Innovation Magazine Summer 2023
Read Summer 2023 Magazine here (PDF)
In this Edition:
UCLA Life Sciences Professors among BIOS Top Women in Academic Entrepreneurship
National News Outlet tells Story of young girl with ADA-SCID
MedTech Partnering Conference 2023 Wrap Up
UCLA Innovation Fellows 2023 Cohort
UCLA Institute of Carbon Management makes great strides in 2023
Promising Data from TORL Therapeutics
Inspiring Women in Science: Yvonne Chen
To help get more girls interested in STEM, let’s spotlight inspiring women in science! A great example is Yvonne Chen, who is doing life-saving research. She is co-founder of ImmPACT Bio, which is based in Camarillo, California. The biotech company recently received positive results in its Phase 1 clinical study in relapsed/refractory B-cell Non-Hodgkin’s Lymphoma (R/R B-cell NHL).
Pfizer Chairman and CEO Dr. Albert Bourla, Keynote Speaker for LABEST 2023
Pfizer Chairman and CEO Dr. Albert Bourla to Keynote LABEST at UCLA Luskin Conference Center on May 25, 2023
TORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics
Congratulations to Dennis Slamon, M.D., Ph.D., Professor of Medicine, and Chief of the Division of Hematology/Oncology at UCLA's David Geffen School of Medicine (DGSOM) (pictured above) co-founder of TORL BioTherapeutics LLC on a successful launch!
Enjoy the Season!
UCLA TDG will be closed from 3pm Thur. Dec 22, 2022 - Mon. Jan. 2, 2023. See you on Tue. Jan 3rd.
UCLA TDG Innovation Magazine Winter 2022
Read Winter 2022 Magazine Here (PDF)
In This Edition:
UCLA TDG Year End 2022 Numbers
UCLA ranks in Pitchbook and Heartland Forward reports
MedTech Updates: Obsidio, SILQ and Spectrum's Dual Lumen Cannula
Water Bear
Device developed by Dr. Abbas Ardehali could improve results for patients undergoing ECMO
Device developed by Dr. Abbas Ardehali could improve results for patients undergoing ECMO
Dr. Abbas Ardehali Photo: UCLA